Your browser is no longer supported. Please, upgrade your browser.
ENDP Endo International plc daily Stock Chart
ENDP [NASD]
Endo International plc
Index- P/E- EPS (ttm)-0.35 Insider Own1.30% Shs Outstand229.72M Perf Week23.93%
Market Cap1.34B Forward P/E2.78 EPS next Y2.09 Insider Trans0.00% Shs Float226.55M Perf Month84.71%
Income-74.70M PEG- EPS next Q0.12 Inst Own82.70% Short Float11.84% Perf Quarter75.23%
Sales3.00B P/S0.45 EPS this Y62.60% Inst Trans0.15% Short Ratio5.58 Perf Half Y71.09%
Book/sh-3.11 P/B- EPS next Y-1.60% ROA-1.70% Target Price5.25 Perf Year24.73%
Cash/sh7.70 P/C0.75 EPS next 5Y- ROE21.10% 52W Range2.08 - 7.10 Perf YTD23.67%
Dividend- P/FCF4.44 EPS past 5Y-43.10% ROI2.70% 52W High-18.31% Beta1.60
Dividend %- Quick Ratio1.90 Sales past 5Y4.10% Gross Margin49.60% 52W Low178.85% ATR0.38
Employees3172 Current Ratio2.20 Sales Q/Q-1.70% Oper. Margin10.50% RSI (14)82.07 Volatility9.50% 9.30%
OptionableYes Debt/Eq- EPS Q/Q117.40% Profit Margin-5.20% Rel Volume1.23 Prev Close5.64
ShortableYes LT Debt/Eq- EarningsNov 05 AMC Payout- Avg Volume4.81M Price5.80
Recom2.90 SMA2043.45% SMA5069.74% SMA20043.22% Volume5,899,031 Change2.84%
Jul-27-20Initiated Goldman Sell $3
Apr-24-20Initiated Citigroup Buy $7
Jan-03-20Upgrade Piper Jaffray Neutral → Overweight $5 → $7
Jul-15-19Downgrade Morgan Stanley Equal-Weight → Underweight
Jun-17-19Downgrade Citigroup Buy → Neutral
Jun-11-19Initiated Barclays Equal Weight
May-13-19Downgrade JP Morgan Neutral → Underweight
Mar-20-19Initiated SunTrust Buy
Mar-05-19Downgrade SVB Leerink Outperform → Mkt Perform
Nov-09-18Upgrade Canaccord Genuity Hold → Buy $16 → $20
Sep-11-18Upgrade Goldman Sell → Neutral
Aug-13-18Upgrade RBC Capital Mkts Sector Perform → Outperform
Aug-09-18Reiterated Stifel Hold $10 → $17
Jun-27-18Upgrade Citigroup Neutral → Buy
Apr-04-18Downgrade Mizuho Buy → Neutral $12 → $7
Feb-28-18Downgrade Gabelli & Co Buy → Hold
Feb-14-18Initiated B. Riley FBR, Inc. Buy $10
Jan-03-18Reiterated Mizuho Buy $14 → $12
Jan-03-18Initiated Leerink Partners Outperform $12
Dec-12-17Initiated Guggenheim Neutral $8.50
Oct-20-20 10:40AM  
Oct-19-20 06:51PM  
04:25PM  
01:50PM  
01:15PM  
10:05AM  
07:30AM  
07:30AM  
Oct-09-20 07:30AM  
Oct-07-20 05:00PM  
08:31AM  
Oct-06-20 05:06PM  
04:26PM  
02:34PM  
02:34PM  
Oct-01-20 05:38PM  
05:38PM  
Sep-28-20 04:41PM  
08:54AM  
Sep-25-20 06:18PM  
04:12PM  
12:09PM  
09:25AM  
09:19AM  
07:35AM  
07:00AM  
07:00AM  
Sep-24-20 07:00AM  
Sep-08-20 05:30PM  
05:30PM  
04:02PM  
11:35AM  
Sep-04-20 11:31AM  
Aug-21-20 08:30PM  
08:30PM  
Aug-18-20 05:47PM  
04:20PM  
02:15PM  
12:01PM  
12:00PM  
11:10AM  
Aug-17-20 05:20PM  
03:53PM  
03:00PM  
02:55PM  
02:00PM  
01:00PM  
12:30PM  
11:56AM  
09:57AM  
08:00AM  
06:20AM  
Aug-16-20 03:10PM  
11:51AM  
10:49AM  
Aug-15-20 02:36PM  
Aug-14-20 02:42PM  
02:35PM  
01:09PM  
01:00PM  
11:25AM  
09:33AM  
Aug-13-20 08:57PM  
07:30PM  
01:40PM  
10:20AM  
09:42AM  
Aug-12-20 06:28PM  
05:00PM  
03:55PM  
02:50PM  
01:45PM  
01:08PM  
11:50AM  
11:38AM  
10:20AM  
09:18AM  
Aug-11-20 11:00AM  
Aug-10-20 03:38PM  
02:07PM  
01:30PM  
01:30PM  
12:00PM  
11:18AM  
06:30AM  
Aug-08-20 08:02PM  
Aug-07-20 02:43PM  
01:15PM  
11:35AM  
Aug-06-20 04:30PM  
03:40PM  
11:00AM  
10:56AM  
10:23AM  
Aug-05-20 10:00PM  
09:47PM  
08:45PM  
07:55PM  
03:35PM  
12:40PM  
Endo International plc manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; TESTOPEL for TRT in conditions associated with a deficiency or absence of endogenous testosterone; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-moderately-severe pain; VOLTAREN gel for the relief of joint pain of osteoarthritis; LIDODERM for the relief of pain; TESTOPEL, an implantable pellet indicated for TRT in conditions; EDEX to treat erectile dysfunction; and LIDODERM a topical patch product containing lidocaine. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays; and products for the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, and oncology. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Coleman BlaiseEVP, Chief Financial OfficerFeb 25Option Exercise0.0030,3950148,724Feb 25 04:44 PM
Campanelli PaulPresident, CEOFeb 25Option Exercise0.00208,4300937,847Feb 25 04:42 PM
Coughlin Terrance JEVP, Chief Operating OfficerFeb 25Option Exercise0.0052,1070308,574Feb 25 04:40 PM
Garella RahulEVP, Intl PharmaceuticalsFeb 25Option Exercise0.009,726040,285Feb 25 04:39 PM
Maletta Matthew JosephEVP, Chief Legal OfficerFeb 25Option Exercise0.0029,5270145,085Feb 25 04:37 PM
Barry Patrick AEVP & Chief Commercial OfficerFeb 25Option Exercise0.0013,199064,960Feb 25 04:35 PM
Boyle Jack D.SVP, ControllerFeb 25Option Exercise0.004,009021,517Feb 25 04:34 PM